| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 6.87e-11 | 44 | 62 | 7 | GO:0046915 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 9.01e-11 | 24 | 62 | 6 | GO:0005385 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.84e-07 | 5 | 62 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 2.84e-06 | 32 | 62 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 7.97e-06 | 13 | 62 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | zinc efflux transmembrane transporter activity | 9.49e-06 | 2 | 62 | 2 | GO:0022883 | |
| GeneOntologyMolecularFunction | monoatomic cation efflux transmembrane transporter activity | 9.49e-06 | 2 | 62 | 2 | GO:0046583 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 1.27e-05 | 465 | 62 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | cadmium ion transmembrane transporter activity | 2.84e-05 | 3 | 62 | 2 | GO:0015086 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | OLIG3 OTX1 SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 FOXA2 OLIG2 GLIS1 CREB5 FOXG1 ZIC3 | 8.54e-05 | 1412 | 62 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | chromatin binding | 8.54e-05 | 739 | 62 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | OLIG3 OTX1 TET1 POU3F1 POU3F4 POU4F1 POU4F2 CHD7 FOXA2 OLIG2 GLIS1 CREB5 ZIC3 | 9.47e-05 | 1244 | 62 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 1.05e-04 | 758 | 62 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | OLIG3 OTX1 TET1 POU3F1 POU3F4 POU4F1 POU4F2 CHD7 FOXA2 OLIG2 GLIS1 CREB5 ZIC3 | 1.18e-04 | 1271 | 62 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | GTF2A1 OLIG3 OTX1 TET1 POU3F1 POU3F4 POU4F1 POU4F2 CHD7 FOXA2 OLIG2 GLIS1 CREB5 ZIC3 | 1.21e-04 | 1459 | 62 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 1.29e-04 | 627 | 62 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 1.52e-04 | 793 | 62 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 1.98e-04 | 664 | 62 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.09e-04 | 296 | 62 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 3.37e-04 | 9 | 62 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.38e-04 | 301 | 62 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 4.20e-04 | 10 | 62 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 5.12e-04 | 11 | 62 | 2 | GO:0005381 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 6.32e-04 | 54 | 62 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 1.11e-03 | 16 | 62 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activator activity | 1.11e-03 | 16 | 62 | 2 | GO:0061575 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.70e-03 | 560 | 62 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.81e-03 | 566 | 62 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.19e-03 | 83 | 62 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.49e-03 | 303 | 62 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.17e-03 | 27 | 62 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 3.24e-03 | 1180 | 62 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.58e-03 | 477 | 62 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.89e-03 | 37 | 62 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | transporter activity | CATSPER1 SLC30A5 SLC11A1 SLC39A9 SLC39A6 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 6.03e-03 | 1289 | 62 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.04e-03 | 119 | 62 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.19e-03 | 120 | 62 | 3 | GO:0008013 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CCNT1 CCNT2 GTF2A1 TSC22D1 OLIG3 ZNF609 OTX1 SLC11A1 TET1 DVL3 AUTS2 POU3F1 CHD8 POU4F1 POU4F2 TNKS CHD7 FOXA2 OLIG2 GLIS1 CREB5 ZIC3 | 3.62e-11 | 1390 | 62 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | zinc ion transmembrane transport | 2.59e-10 | 29 | 62 | 6 | GO:0071577 | |
| GeneOntologyBiologicalProcess | zinc ion transport | 3.23e-10 | 30 | 62 | 6 | GO:0006829 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 3.72e-09 | 44 | 62 | 6 | GO:0006882 | |
| GeneOntologyBiologicalProcess | head development | SEMA3A OTX1 NRXN1 ARID5B DVL3 GSX2 POU3F1 POU3F4 CHD8 POU4F1 CHD7 RERE FOXA2 OLIG2 FOXG1 ZIC3 | 8.42e-09 | 919 | 62 | 16 | GO:0060322 |
| GeneOntologyBiologicalProcess | zinc ion import across plasma membrane | 2.40e-08 | 11 | 62 | 4 | GO:0071578 | |
| GeneOntologyBiologicalProcess | brain development | SEMA3A OTX1 NRXN1 DVL3 GSX2 POU3F1 POU3F4 CHD8 POU4F1 CHD7 RERE FOXA2 OLIG2 FOXG1 ZIC3 | 2.60e-08 | 859 | 62 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | transition metal ion transport | 4.71e-08 | 113 | 62 | 7 | GO:0000041 | |
| GeneOntologyBiologicalProcess | central nervous system development | SEMA3A OLIG3 OTX1 ATN1 NRXN1 DVL3 GSX2 POU3F1 POU3F4 CHD8 POU4F1 CHD7 RERE FOXA2 OLIG2 FOXG1 ZIC3 | 5.27e-08 | 1197 | 62 | 17 | GO:0007417 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 2.74e-07 | 217 | 62 | 8 | GO:0021953 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 3.15e-07 | 91 | 62 | 6 | GO:0048663 | |
| GeneOntologyBiologicalProcess | axon development | SEMA3A OLIG3 NEO1 NRXN3 NRXN1 AUTS2 SHOX2 POU4F1 POU4F2 OLIG2 TENM2 FOXG1 | 3.88e-07 | 642 | 62 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA3A NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE TENM2 FOXG1 | 6.00e-07 | 802 | 62 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | vocalization behavior | 7.52e-07 | 24 | 62 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA3A NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE TENM2 FOXG1 | 7.60e-07 | 819 | 62 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA3A NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE TENM2 FOXG1 | 8.37e-07 | 826 | 62 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 1.82e-06 | 611 | 62 | 11 | GO:0030003 |
| GeneOntologyBiologicalProcess | forebrain development | 1.82e-06 | 489 | 62 | 10 | GO:0030900 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA3A NEO1 NRXN3 NRXN1 TET1 AUTS2 SHOX2 POU4F1 POU4F2 RERE TENM2 FOXG1 | 1.93e-06 | 748 | 62 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 2.16e-06 | 622 | 62 | 11 | GO:0006873 |
| GeneOntologyBiologicalProcess | neuron migration | 4.02e-06 | 218 | 62 | 7 | GO:0001764 | |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA3A OLIG3 NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE OLIG2 TENM2 FOXG1 | 4.41e-06 | 1285 | 62 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | bicarbonate transport | 5.06e-06 | 38 | 62 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA3A NEO1 NRXN3 NRXN1 AUTS2 SHOX2 POU4F1 POU4F2 TENM2 FOXG1 | 6.66e-06 | 566 | 62 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 6.84e-06 | 154 | 62 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 7.14e-06 | 705 | 62 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | neuron fate specification | 7.60e-06 | 42 | 62 | 4 | GO:0048665 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 8.38e-06 | 717 | 62 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 FOXA2 SLC4A3 SLC39A7 | 8.66e-06 | 866 | 62 | 12 | GO:0055082 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | OLIG3 ATN1 TET1 ARID5B SHOX2 POU3F1 CHD8 POU4F1 POU4F2 OLIG2 TENM2 GLIS1 FOXG1 | 1.20e-05 | 1053 | 62 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | OLIG3 ATN1 TET1 ARID5B SHOX2 POU3F1 CHD8 POU4F1 POU4F2 ZNF318 RERE OLIG2 TENM2 GLIS1 FOXG1 | 1.23e-05 | 1399 | 62 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | OLIG3 ATN1 TET1 ARID5B SHOX2 POU3F1 CHD8 POU4F1 POU4F2 ZNF318 RERE OLIG2 TENM2 GLIS1 FOXG1 | 1.39e-05 | 1413 | 62 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.41e-05 | 16 | 62 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 SLC39A7 | 1.51e-05 | 622 | 62 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | SEMA3A NRXN1 IQSEC2 SHOX2 GSX2 POU4F1 POU4F2 CHD7 OLIG2 FOXG1 | 1.58e-05 | 625 | 62 | 10 | GO:0051960 |
| GeneOntologyBiologicalProcess | embryo development | SEMA3A OTX1 BRPF1 INSL3 TET1 DVL3 SHOX2 TRIM71 POU3F4 CHD8 CHD7 FOXA2 FOXG1 AXIN2 ZIC3 | 1.69e-05 | 1437 | 62 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SEMA3A OTX1 ARID5B DVL3 SHOX2 FGFRL1 GSX2 POU3F4 POU4F1 CHD7 FOXA2 FOXG1 AXIN2 ZIC3 | 1.86e-05 | 1269 | 62 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | olfactory bulb development | 1.94e-05 | 53 | 62 | 4 | GO:0021772 | |
| GeneOntologyBiologicalProcess | neuron development | SEMA3A OLIG3 NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE OLIG2 TENM2 FOXG1 | 2.09e-05 | 1463 | 62 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon guidance | 2.29e-05 | 285 | 62 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.35e-05 | 286 | 62 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 2.42e-05 | 56 | 62 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 2.42e-05 | 56 | 62 | 4 | GO:0021988 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 2.42e-05 | 56 | 62 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 FOXA2 SLC4A3 SLC39A7 | 3.00e-05 | 981 | 62 | 12 | GO:0019725 |
| GeneOntologyBiologicalProcess | cell fate specification | 3.43e-05 | 123 | 62 | 5 | GO:0001708 | |
| GeneOntologyBiologicalProcess | hindbrain development | 3.76e-05 | 208 | 62 | 6 | GO:0030902 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CATSPER1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 4.26e-05 | 1017 | 62 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 4.31e-05 | 129 | 62 | 5 | GO:0042472 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA3A NEO1 NRXN3 NRXN1 TET1 DVL3 AUTS2 SHOX2 POU4F1 POU4F2 RERE TENM2 FOXG1 | 4.48e-05 | 1194 | 62 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.84e-05 | 713 | 62 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 4.89e-05 | 321 | 62 | 7 | GO:0003007 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 5.31e-05 | 4 | 62 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 5.67e-05 | 25 | 62 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 6.40e-05 | 26 | 62 | 3 | GO:0099550 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 6.77e-05 | 338 | 62 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | BRPF1 INSL3 TET1 DVL3 SHOX2 TRIM71 CHD8 CHD7 FOXA2 AXIN2 ZIC3 | 7.20e-05 | 906 | 62 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | social behavior | 7.27e-05 | 74 | 62 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | connective tissue development | 7.42e-05 | 343 | 62 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 8.07e-05 | 76 | 62 | 4 | GO:0051703 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CATSPER1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 8.42e-05 | 922 | 62 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 8.57e-05 | 351 | 62 | 7 | GO:0048562 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SEMA3A TSC22D1 ZNF609 BRPF1 SHOX2 GSX2 POU4F1 POU4F2 CHD7 OLIG2 FOXG1 AXIN2 | 8.67e-05 | 1095 | 62 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid receptor clustering | 8.84e-05 | 5 | 62 | 2 | GO:0097112 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 8.84e-05 | 5 | 62 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | BRPF1 INSL3 TET1 DVL3 SHOX2 TRIM71 CHD8 CHD7 FOXA2 AXIN2 ZIC3 | 9.01e-05 | 929 | 62 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CATSPER1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 1.02e-04 | 942 | 62 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CATSPER1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 CACHD1 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 1.03e-04 | 1115 | 62 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | receptor clustering | 1.14e-04 | 83 | 62 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 1.23e-04 | 161 | 62 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cadmium ion transport | 1.32e-04 | 6 | 62 | 2 | GO:0015691 | |
| GeneOntologyBiologicalProcess | cadmium ion transmembrane transport | 1.32e-04 | 6 | 62 | 2 | GO:0070574 | |
| GeneOntologyBiologicalProcess | cell junction organization | SEMA3A SORBS2 NRXN3 NRXN1 NRXN2 SLC39A9 IQSEC2 HRG POU4F1 PRRT1 SHISA7 | 1.37e-04 | 974 | 62 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.45e-04 | 34 | 62 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | innervation | 1.45e-04 | 34 | 62 | 3 | GO:0060384 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.48e-04 | 515 | 62 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | diencephalon development | 1.56e-04 | 90 | 62 | 4 | GO:0021536 | |
| GeneOntologyBiologicalProcess | metal ion transport | CATSPER1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 CACHD1 SLC39A14 SLC39A10 SLC39A7 | 1.72e-04 | 1000 | 62 | 11 | GO:0030001 |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 1.84e-04 | 94 | 62 | 4 | GO:0045665 | |
| GeneOntologyBiologicalProcess | vocal learning | 1.85e-04 | 7 | 62 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 1.85e-04 | 7 | 62 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.96e-04 | 685 | 62 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | ear development | 2.12e-04 | 285 | 62 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.51e-04 | 418 | 62 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 2.52e-04 | 102 | 62 | 4 | GO:0048644 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | NEO1 SLC30A5 SLC11A1 SLC39A9 HRC SLC39A6 CHD7 SLC39A14 SLC39A10 FOXA2 SLC4A3 SLC39A7 | 2.97e-04 | 1249 | 62 | 12 | GO:0048878 |
| GeneOntologyBiologicalProcess | circulatory system development | SORBS2 NRXN3 NRXN1 BRPF1 DVL3 HRG SHOX2 FGFRL1 POU4F1 POU4F2 CHD7 AXIN2 ZIC3 | 2.97e-04 | 1442 | 62 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | behavior | 3.01e-04 | 891 | 62 | 10 | GO:0007610 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 3.03e-04 | 107 | 62 | 4 | GO:0009953 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 3.14e-04 | 44 | 62 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | sensory organ development | 3.14e-04 | 730 | 62 | 9 | GO:0007423 | |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 3.16e-04 | 9 | 62 | 2 | GO:0003223 | |
| GeneOntologyBiologicalProcess | observational learning | 3.16e-04 | 9 | 62 | 2 | GO:0098597 | |
| GeneOntologyBiologicalProcess | muscle organ development | 3.24e-04 | 436 | 62 | 7 | GO:0007517 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 3.58e-04 | 46 | 62 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | adult behavior | 3.61e-04 | 203 | 62 | 5 | GO:0030534 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 3.82e-04 | 750 | 62 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 3.99e-04 | 115 | 62 | 4 | GO:0035418 | |
| GeneOntologyBiologicalProcess | heart development | 4.09e-04 | 757 | 62 | 9 | GO:0007507 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.40e-04 | 212 | 62 | 5 | GO:0003205 | |
| GeneOntologyCellularComponent | chromatin | OLIG3 OTX1 BRPF1 TET1 DVL3 SHOX2 GSX2 POU3F1 POU3F4 CHD8 POU4F1 POU4F2 CHD7 FOXA2 OLIG2 CREB5 FOXG1 | 6.93e-07 | 1480 | 61 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | glutamatergic synapse | SEMA3A NEO1 NRXN3 NRXN1 NRXN2 IQSEC2 DVL3 PRRT1 TENM2 SHISA7 | 1.16e-04 | 817 | 61 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | synaptic membrane | 2.80e-04 | 583 | 61 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 2.98e-04 | 9 | 61 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | presynaptic active zone | 7.68e-04 | 141 | 61 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.15e-03 | 157 | 61 | 4 | GO:0098839 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 1.24e-03 | 18 | 61 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.54e-03 | 78 | 61 | 3 | GO:0048787 | |
| MousePheno | abnormal neurocranium morphology | 1.48e-06 | 269 | 58 | 9 | MP:0000074 | |
| MousePheno | abnormal nervous system development | SEMA3A OLIG3 OTX1 IQSEC2 TET1 AUTS2 FGFRL1 GSX2 TRIM71 CHD8 TNKS CHD7 RERE FOXA2 OLIG2 FOXG1 AXIN2 ZIC3 | 1.80e-06 | 1257 | 58 | 18 | MP:0003861 |
| MousePheno | abnormal cranium morphology | OTX1 TET1 ARID5B DVL3 SHOX2 FGFRL1 TRIM71 POU3F4 CHD7 CACHD1 FOXA2 FOXG1 AXIN2 ZIC3 | 4.18e-06 | 813 | 58 | 14 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | OTX1 TET1 ARID5B DVL3 SHOX2 FGFRL1 TRIM71 POU3F4 CHD7 CACHD1 FOXA2 FOXG1 AXIN2 ZIC3 | 5.09e-06 | 827 | 58 | 14 | MP:0002116 |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 8.16e-06 | 116 | 58 | 6 | MP:0004753 | |
| MousePheno | abnormal brain development | OLIG3 OTX1 TET1 FGFRL1 GSX2 TRIM71 TNKS CHD7 RERE OLIG2 FOXG1 ZIC3 | 9.53e-06 | 638 | 58 | 12 | MP:0000913 |
| MousePheno | abnormal somatic nervous system morphology | SEMA3A NEO1 DVL3 AUTS2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 CHD7 CACHD1 OLIG2 TENM2 SLC4A3 ZIC3 | 1.28e-05 | 1025 | 58 | 15 | MP:0002752 |
| MousePheno | abnormal neuron differentiation | 1.66e-05 | 275 | 58 | 8 | MP:0009937 | |
| MousePheno | neonatal lethality | GTF2A1 OLIG3 OTX1 ARID5B AUTS2 FGFRL1 GSX2 POU3F1 POU4F1 FOXA2 OLIG2 CREB5 FOXG1 | 1.81e-05 | 799 | 58 | 13 | MP:0002058 |
| MousePheno | abnormal telencephalon morphology | SEMA3A OLIG3 OTX1 IQSEC2 TET1 GSX2 POU3F1 TRIM71 CHD7 RERE TENM2 FOXG1 ZIC3 | 2.15e-05 | 812 | 58 | 13 | MP:0000787 |
| MousePheno | abnormal forebrain morphology | SEMA3A OLIG3 OTX1 IQSEC2 TET1 FGFRL1 GSX2 POU3F1 TRIM71 POU4F1 CHD7 RERE TENM2 FOXG1 ZIC3 | 2.18e-05 | 1072 | 58 | 15 | MP:0000783 |
| MousePheno | abnormal stationary movement | 3.15e-05 | 147 | 58 | 6 | MP:0001388 | |
| MousePheno | abnormal midbrain morphology | 3.66e-05 | 151 | 58 | 6 | MP:0000897 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SEMA3A GTF2A1 OTX1 SORBS2 NRXN3 ATN1 ARID5B DVL3 SHOX2 FGFRL1 POU3F1 CHD7 RERE FOXA2 ZIC3 | 3.80e-05 | 1124 | 58 | 15 | MP:0011112 |
| MousePheno | abnormal forebrain development | 3.82e-05 | 225 | 58 | 7 | MP:0003232 | |
| MousePheno | abnormal sensory neuron innervation pattern | 3.85e-05 | 92 | 58 | 5 | MP:0000968 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | OLIG3 NEO1 OTX1 DVL3 AUTS2 SHOX2 FGFRL1 GSX2 POU3F1 TRIM71 POU4F1 RERE FOXA2 OLIG2 CREB5 FOXG1 | 3.93e-05 | 1269 | 58 | 16 | MP:0011111 |
| MousePheno | abnormal brainstem morphology | 4.04e-05 | 227 | 58 | 7 | MP:0005277 | |
| MousePheno | perinatal lethality | GTF2A1 OLIG3 NEO1 OTX1 ARID5B AUTS2 FGFRL1 GSX2 POU3F1 POU4F1 RERE FOXA2 OLIG2 CREB5 FOXG1 | 4.04e-05 | 1130 | 58 | 15 | MP:0002081 |
| MousePheno | abnormal cranial nerve morphology | 4.28e-05 | 314 | 58 | 8 | MP:0001056 | |
| MousePheno | abnormal stapes footplate morphology | 5.06e-05 | 3 | 58 | 2 | MP:0004290 | |
| MousePheno | abnormal axial skeleton morphology | SEMA3A OTX1 SLC30A5 TET1 ARID5B DVL3 SHOX2 FGFRL1 TRIM71 POU3F4 CHD7 CACHD1 SLC39A14 FOXA2 FOXG1 AXIN2 ZIC3 | 5.70e-05 | 1458 | 58 | 17 | MP:0002114 |
| MousePheno | abnormal facial morphology | TET1 ARID5B DVL3 SHOX2 FGFRL1 GSX2 TRIM71 CHD7 RERE FOXA2 FOXG1 AXIN2 ZIC3 | 7.03e-05 | 910 | 58 | 13 | MP:0003743 |
| MousePheno | abnormal hippocampus size | 7.77e-05 | 55 | 58 | 4 | MP:0008281 | |
| MousePheno | abnormal lateral semicircular canal morphology | 8.55e-05 | 21 | 58 | 3 | MP:0000037 | |
| MousePheno | abnormal superior colliculus morphology | 8.55e-05 | 21 | 58 | 3 | MP:0000904 | |
| MousePheno | head shaking | 9.87e-05 | 22 | 58 | 3 | MP:0002730 | |
| MousePheno | abnormal craniofacial morphology | OTX1 TET1 ARID5B DVL3 SHOX2 FGFRL1 GSX2 TRIM71 POU3F4 CHD7 CACHD1 RERE FOXA2 FOXG1 AXIN2 ZIC3 | 1.01e-04 | 1372 | 58 | 16 | MP:0000428 |
| MousePheno | craniofacial phenotype | OTX1 TET1 ARID5B DVL3 SHOX2 FGFRL1 GSX2 TRIM71 POU3F4 CHD7 CACHD1 RERE FOXA2 FOXG1 AXIN2 ZIC3 | 1.01e-04 | 1372 | 58 | 16 | MP:0005382 |
| MousePheno | abnormal inferior olivary complex morphology | 1.01e-04 | 4 | 58 | 2 | MP:0003684 | |
| MousePheno | postnatal lethality | SEMA3A OTX1 SORBS2 NRXN3 ATN1 NRXN2 ARID5B DVL3 SHOX2 POU3F1 CHD7 RERE FOXA2 ZIC3 | 1.04e-04 | 1084 | 58 | 14 | MP:0002082 |
| MousePheno | circling | 1.21e-04 | 117 | 58 | 5 | MP:0001394 | |
| MousePheno | abnormal somatic sensory system morphology | SEMA3A DVL3 GSX2 POU3F4 POU4F1 POU4F2 CHD7 CACHD1 OLIG2 TENM2 SLC4A3 | 1.24e-04 | 702 | 58 | 11 | MP:0000959 |
| MousePheno | perinatal lethality, complete penetrance | OLIG3 NEO1 OTX1 AUTS2 FGFRL1 GSX2 POU4F1 RERE OLIG2 CREB5 FOXG1 | 1.41e-04 | 712 | 58 | 11 | MP:0011089 |
| MousePheno | abnormal head morphology | TET1 ARID5B DVL3 SHOX2 FGFRL1 GSX2 TRIM71 CHD8 CHD7 RERE FOXA2 FOXG1 AXIN2 ZIC3 | 1.48e-04 | 1120 | 58 | 14 | MP:0000432 |
| MousePheno | abnormal limbic system morphology | 1.56e-04 | 378 | 58 | 8 | MP:0004166 | |
| MousePheno | abnormal cerebral hemisphere morphology | 1.57e-04 | 599 | 58 | 10 | MP:0008540 | |
| MousePheno | abnormal oval window morphology | 1.68e-04 | 5 | 58 | 2 | MP:0004479 | |
| MousePheno | abnormal interfrontal bone morphology | 1.68e-04 | 5 | 58 | 2 | MP:0008818 | |
| MousePheno | abnormal stapes crus morpholgy | 1.68e-04 | 5 | 58 | 2 | MP:0030407 | |
| MousePheno | abnormal neuron physiology | 1.68e-04 | 604 | 58 | 10 | MP:0004811 | |
| MousePheno | abnormal telencephalon development | 1.72e-04 | 126 | 58 | 5 | MP:0000934 | |
| MousePheno | abnormal nose morphology | 1.78e-04 | 201 | 58 | 6 | MP:0002233 | |
| MousePheno | abnormal diencephalon morphology | 2.21e-04 | 298 | 58 | 7 | MP:0000830 | |
| MousePheno | unilateral cryptorchism | 2.51e-04 | 6 | 58 | 2 | MP:0031286 | |
| MousePheno | facial asymmetry | 2.51e-04 | 6 | 58 | 2 | MP:0030099 | |
| MousePheno | neonatal lethality, complete penetrance | 3.24e-04 | 534 | 58 | 9 | MP:0011087 | |
| MousePheno | cyanosis | 3.35e-04 | 226 | 58 | 6 | MP:0001575 | |
| MousePheno | abnormal cranial foramen morphology | 3.39e-04 | 33 | 58 | 3 | MP:0030310 | |
| MousePheno | craniofacial asymmetry | 3.51e-04 | 7 | 58 | 2 | MP:0008863 | |
| MousePheno | bilateral cryptorchism | 3.51e-04 | 7 | 58 | 2 | MP:0031287 | |
| MousePheno | abnormal cell differentiation | SEMA3A OLIG3 TET1 AUTS2 GSX2 TRIM71 CHD7 FOXA2 OLIG2 FOXG1 AXIN2 | 3.66e-04 | 795 | 58 | 11 | MP:0005076 |
| MousePheno | abnormal olfactory lobe morphology | 3.74e-04 | 149 | 58 | 5 | MP:0009944 | |
| MousePheno | postnatal lethality, incomplete penetrance | 3.83e-04 | 669 | 58 | 10 | MP:0011086 | |
| MousePheno | abnormal cerebral cortex morphology | 3.95e-04 | 328 | 58 | 7 | MP:0000788 | |
| MousePheno | abnormal tectum morphology | 4.04e-04 | 35 | 58 | 3 | MP:0006104 | |
| MousePheno | abnormal midbrain roof plate morphology | 4.04e-04 | 35 | 58 | 3 | MP:0006103 | |
| MousePheno | abnormal corpora quadrigemina morphology | 4.04e-04 | 35 | 58 | 3 | MP:0000899 | |
| MousePheno | abnormal hippocampus morphology | 4.18e-04 | 331 | 58 | 7 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 4.65e-04 | 337 | 58 | 7 | MP:0000801 | |
| MousePheno | abnormal cerebellum vermis lobule morphology | 4.66e-04 | 8 | 58 | 2 | MP:0009957 | |
| MousePheno | abnormal cerebellar hemisphere morphology | 5.98e-04 | 9 | 58 | 2 | MP:0009959 | |
| MousePheno | abnormal face development | 5.98e-04 | 9 | 58 | 2 | MP:0030313 | |
| MousePheno | abnormal oxygen level | 6.49e-04 | 256 | 58 | 6 | MP:0001574 | |
| MousePheno | abnormal reflex | CCNT1 CCNT2 SORBS2 ATN1 AUTS2 POU3F4 CHD8 POU4F1 POU4F2 CHD7 FOXA2 OLIG2 AXIN2 ZIC3 | 6.55e-04 | 1294 | 58 | 14 | MP:0001961 |
| MousePheno | abnormal cranium size | 6.94e-04 | 97 | 58 | 4 | MP:0010031 | |
| MousePheno | abnormal sensory neuron morphology | 7.02e-04 | 473 | 58 | 8 | MP:0000965 | |
| MousePheno | abnormal neuron proliferation | 7.21e-04 | 98 | 58 | 4 | MP:0009967 | |
| MousePheno | abnormal gas homeostasis | 7.55e-04 | 600 | 58 | 9 | MP:0003948 | |
| MousePheno | abnormal food intake | 7.83e-04 | 481 | 58 | 8 | MP:0005449 | |
| MousePheno | abnormal eating behavior | 7.91e-04 | 604 | 58 | 9 | MP:0001431 | |
| MousePheno | postnatal growth retardation | OTX1 SLC30A5 IQSEC2 ARID5B SHOX2 CHD7 RERE SLC39A14 FOXA2 AXIN2 ZIC3 | 8.67e-04 | 881 | 58 | 11 | MP:0001732 |
| MousePheno | abnormal head movements | 8.69e-04 | 103 | 58 | 4 | MP:0000436 | |
| MousePheno | abnormal brain size | 8.75e-04 | 375 | 58 | 7 | MP:0000771 | |
| MousePheno | small hippocampus | 9.07e-04 | 46 | 58 | 3 | MP:0008283 | |
| MousePheno | abnormal primitive streak elongation | 9.08e-04 | 11 | 58 | 2 | MP:0012685 | |
| MousePheno | abnormal olfactory epithelium morphology | 1.03e-03 | 48 | 58 | 3 | MP:0008789 | |
| MousePheno | abnormal bony labyrinth | 1.09e-03 | 12 | 58 | 2 | MP:0004289 | |
| MousePheno | dilated endolymphatic duct | 1.09e-03 | 12 | 58 | 2 | MP:0006012 | |
| MousePheno | abnormal postnatal growth | OTX1 SLC30A5 IQSEC2 ARID5B SHOX2 CHD7 RERE SLC39A14 FOXA2 AXIN2 ZIC3 | 1.10e-03 | 907 | 58 | 11 | MP:0001731 |
| MousePheno | abnormal brain ventricular system morphology | 1.15e-03 | 393 | 58 | 7 | MP:0002200 | |
| MousePheno | abnormal brain ventricle morphology | 1.15e-03 | 286 | 58 | 6 | MP:0000822 | |
| MousePheno | abnormal innervation | 1.21e-03 | 193 | 58 | 5 | MP:0002184 | |
| MousePheno | abnormal joint morphology | 1.22e-03 | 397 | 58 | 7 | MP:0002932 | |
| MousePheno | absent lateral semicircular canal | 1.28e-03 | 13 | 58 | 2 | MP:0003161 | |
| MousePheno | abnormal nasal placode morphology | 1.28e-03 | 13 | 58 | 2 | MP:0006292 | |
| MousePheno | abnormal trigeminal nerve morphology | 1.30e-03 | 52 | 58 | 3 | MP:0001065 | |
| MousePheno | decreased brain size | 1.35e-03 | 295 | 58 | 6 | MP:0000774 | |
| MousePheno | small olfactory bulb | 1.37e-03 | 53 | 58 | 3 | MP:0002741 | |
| MousePheno | abnormal thalamus morphology | 1.45e-03 | 54 | 58 | 3 | MP:0000832 | |
| MousePheno | abnormal breathing pattern | 1.55e-03 | 303 | 58 | 6 | MP:0001951 | |
| MousePheno | abnormal olfactory system morphology | 1.61e-03 | 56 | 58 | 3 | MP:0005499 | |
| MousePheno | abnormal cricoid cartilage morphology | 1.72e-03 | 15 | 58 | 2 | MP:0002258 | |
| MousePheno | abnormal synovial joint morphology | 1.73e-03 | 124 | 58 | 4 | MP:0030804 | |
| MousePheno | abnormal semicircular canal morphology | 1.87e-03 | 59 | 58 | 3 | MP:0002428 | |
| MousePheno | stereotypic behavior | 1.90e-03 | 214 | 58 | 5 | MP:0001408 | |
| MousePheno | split xiphoid process | 1.96e-03 | 16 | 58 | 2 | MP:0004678 | |
| MousePheno | abnormal visual cortex morphology | 1.96e-03 | 16 | 58 | 2 | MP:0000805 | |
| MousePheno | abnormal superior semicircular canal morphology | 1.96e-03 | 16 | 58 | 2 | MP:0003069 | |
| MousePheno | abnormal visual evoked potential | 1.96e-03 | 16 | 58 | 2 | MP:0010748 | |
| Domain | Zip | 6.69e-10 | 14 | 62 | 5 | PF02535 | |
| Domain | ZIP | 6.69e-10 | 14 | 62 | 5 | IPR003689 | |
| Domain | POU | 1.94e-07 | 16 | 62 | 4 | SM00352 | |
| Domain | POU_2 | 1.94e-07 | 16 | 62 | 4 | PS00465 | |
| Domain | POU_dom | 1.94e-07 | 16 | 62 | 4 | IPR000327 | |
| Domain | POU_3 | 1.94e-07 | 16 | 62 | 4 | PS51179 | |
| Domain | Pou | 1.94e-07 | 16 | 62 | 4 | PF00157 | |
| Domain | POU_1 | 1.94e-07 | 16 | 62 | 4 | PS00035 | |
| Domain | POU | 2.54e-07 | 17 | 62 | 4 | IPR013847 | |
| Domain | Syndecan | 1.21e-06 | 7 | 62 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.21e-06 | 7 | 62 | 3 | IPR027789 | |
| Domain | - | 1.82e-06 | 27 | 62 | 4 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 2.46e-06 | 29 | 62 | 4 | IPR010982 | |
| Domain | Homeobox_CS | 2.69e-06 | 186 | 62 | 7 | IPR017970 | |
| Domain | Atrophin-like | 1.08e-05 | 2 | 62 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 1.08e-05 | 2 | 62 | 2 | PF03154 | |
| Domain | Homeobox | 1.21e-05 | 234 | 62 | 7 | PF00046 | |
| Domain | Neurexin-like | 1.24e-05 | 14 | 62 | 3 | IPR003585 | |
| Domain | 4.1m | 1.24e-05 | 14 | 62 | 3 | SM00294 | |
| Domain | HOMEOBOX_1 | 1.28e-05 | 236 | 62 | 7 | PS00027 | |
| Domain | HOX | 1.32e-05 | 237 | 62 | 7 | SM00389 | |
| Domain | Homeodomain-like | 1.34e-05 | 332 | 62 | 8 | IPR009057 | |
| Domain | HOMEOBOX_2 | 1.39e-05 | 239 | 62 | 7 | PS50071 | |
| Domain | Homeobox_dom | 1.39e-05 | 239 | 62 | 7 | IPR001356 | |
| Domain | AUTS2 | 3.25e-05 | 3 | 62 | 2 | IPR023246 | |
| Domain | - | 4.11e-05 | 283 | 62 | 7 | 1.10.10.60 | |
| Domain | TF_POU_3 | 6.48e-05 | 4 | 62 | 2 | IPR016362 | |
| Domain | BRK | 1.61e-04 | 6 | 62 | 2 | SM00592 | |
| Domain | BRK_domain | 1.61e-04 | 6 | 62 | 2 | IPR006576 | |
| Domain | BRK | 1.61e-04 | 6 | 62 | 2 | PF07533 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.11e-04 | 35 | 62 | 3 | IPR002464 | |
| Domain | DIX | 2.25e-04 | 7 | 62 | 2 | PF00778 | |
| Domain | DIX | 2.25e-04 | 7 | 62 | 2 | IPR001158 | |
| Domain | DIX | 2.25e-04 | 7 | 62 | 2 | PS50841 | |
| Domain | DAX | 2.25e-04 | 7 | 62 | 2 | SM00021 | |
| Domain | DEAH_ATP_HELICASE | 2.71e-04 | 38 | 62 | 3 | PS00690 | |
| Domain | LAM_G_DOMAIN | 2.71e-04 | 38 | 62 | 3 | PS50025 | |
| Domain | Cyclin_L/T | 3.00e-04 | 8 | 62 | 2 | IPR015429 | |
| Domain | Laminin_G_2 | 3.15e-04 | 40 | 62 | 3 | PF02210 | |
| Domain | LamG | 4.19e-04 | 44 | 62 | 3 | SM00282 | |
| Domain | NHL | 8.26e-04 | 13 | 62 | 2 | PS51125 | |
| Domain | Laminin_G | 9.44e-04 | 58 | 62 | 3 | IPR001791 | |
| Domain | Chromo_domain | 2.85e-03 | 24 | 62 | 2 | IPR023780 | |
| Domain | Chromo | 3.35e-03 | 26 | 62 | 2 | PF00385 | |
| Domain | CHROMO_1 | 3.88e-03 | 28 | 62 | 2 | PS00598 | |
| Domain | CHROMO_2 | 3.88e-03 | 28 | 62 | 2 | PS50013 | |
| Domain | CYCLINS | 3.88e-03 | 28 | 62 | 2 | PS00292 | |
| Domain | - | 3.88e-03 | 95 | 62 | 3 | 2.60.120.200 | |
| Domain | SNF2_N | 5.04e-03 | 32 | 62 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 5.04e-03 | 32 | 62 | 2 | IPR016197 | |
| Domain | SNF2_N | 5.04e-03 | 32 | 62 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 5.36e-03 | 33 | 62 | 2 | IPR000953 | |
| Domain | Cyclin_N | 5.36e-03 | 33 | 62 | 2 | IPR006671 | |
| Domain | Cyclin_N | 5.36e-03 | 33 | 62 | 2 | PF00134 | |
| Domain | CHROMO | 5.36e-03 | 33 | 62 | 2 | SM00298 | |
| Domain | Helicase_C | 5.41e-03 | 107 | 62 | 3 | PF00271 | |
| Domain | HELICc | 5.41e-03 | 107 | 62 | 3 | SM00490 | |
| Domain | Helicase_C | 5.55e-03 | 108 | 62 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.70e-03 | 109 | 62 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.70e-03 | 109 | 62 | 3 | PS51192 | |
| Domain | DEXDc | 5.70e-03 | 109 | 62 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.84e-03 | 110 | 62 | 3 | IPR014001 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 1.87e-10 | 24 | 50 | 6 | M18795 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 1.34e-09 | 15 | 50 | 5 | M832 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 3.12e-09 | 37 | 50 | 6 | M39377 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 6.81e-09 | 20 | 50 | 5 | MM15077 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 2.89e-08 | 10 | 50 | 4 | M27361 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 4.54e-08 | 11 | 50 | 4 | MM15101 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 4.81e-07 | 84 | 50 | 6 | M27334 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 2.32e-06 | 8 | 50 | 3 | MM15106 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 4.68e-06 | 32 | 50 | 4 | MM15326 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.99e-06 | 76 | 50 | 5 | MM15072 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.59e-05 | 153 | 50 | 6 | M39546 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.58e-05 | 249 | 50 | 7 | M5988 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 9.10e-05 | 67 | 50 | 4 | MM15327 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 1.16e-04 | 27 | 50 | 3 | M45550 | |
| Pathway | WP_NRF2_PATHWAY | 1.38e-04 | 141 | 50 | 5 | M39454 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.86e-04 | 238 | 50 | 6 | MM15076 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.13e-04 | 33 | 50 | 3 | M39875 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.81e-04 | 97 | 50 | 4 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 4.44e-04 | 101 | 50 | 4 | M39448 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 8.11e-04 | 314 | 50 | 6 | M39428 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.02e-03 | 56 | 50 | 3 | M27616 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.09e-03 | 14 | 50 | 2 | M27638 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.09e-03 | 14 | 50 | 2 | MM15341 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.25e-03 | 133 | 50 | 4 | M16476 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 1.50e-03 | 64 | 50 | 3 | M200 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.63e-03 | 143 | 50 | 4 | M39591 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.82e-03 | 18 | 50 | 2 | M31 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 1.94e-03 | 70 | 50 | 3 | M27008 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 2.19e-03 | 73 | 50 | 3 | M39401 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 2.19e-03 | 73 | 50 | 3 | MM15349 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.34e-03 | 158 | 50 | 4 | MM14791 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 2.85e-03 | 80 | 50 | 3 | M223 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 2.95e-03 | 81 | 50 | 3 | M27647 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 2.95e-03 | 81 | 50 | 3 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 3.16e-03 | 83 | 50 | 3 | MM15314 | |
| Pathway | WP_KALLMANN_SYNDROME | 3.24e-03 | 24 | 50 | 2 | M42530 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.61e-03 | 87 | 50 | 3 | M27617 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 3.79e-03 | 26 | 50 | 2 | M47439 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 3.79e-03 | 26 | 50 | 2 | MM14878 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.32e-03 | 304 | 50 | 5 | MM14960 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 5.04e-03 | 98 | 50 | 3 | M39731 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 5.37e-03 | 31 | 50 | 2 | M27393 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DHX15 CCNT1 CCNT2 GTF2A1 TSC22D1 ZNF609 OTX1 ATN1 IQSEC2 ARID5B AUTS2 SLC39A6 FGFRL1 CHD8 TNKS RERE SLC39A14 SLC39A10 FOXA2 CREB5 SLC39A7 FOXG1 ZIC3 | 5.08e-18 | 1203 | 63 | 23 | 29180619 |
| Pubmed | 2.95e-11 | 33 | 63 | 6 | 19336002 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TSC22D1 OLIG3 OTX1 SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 RERE FOXA2 OLIG2 GLIS1 CREB5 FOXG1 | 6.05e-11 | 908 | 63 | 15 | 19274049 |
| Pubmed | 1.27e-10 | 134 | 63 | 8 | 19030180 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | OLIG3 OTX1 GSX2 POU3F1 POU3F4 POU4F1 FOXA2 OLIG2 GLIS1 CREB5 FOXG1 ZIC3 | 2.46e-10 | 544 | 63 | 12 | 28473536 |
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 4.26e-10 | 22 | 63 | 5 | 36395107 | |
| Pubmed | 4.03e-09 | 130 | 63 | 7 | 19386638 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 5.66e-09 | 3 | 63 | 3 | 34133920 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 38891114 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 30858964 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 28013231 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 16406382 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 5.66e-09 | 3 | 63 | 3 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 5.66e-09 | 3 | 63 | 3 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 5.66e-09 | 3 | 63 | 3 | 29045040 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 31005376 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 38571813 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 35173587 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 5.66e-09 | 3 | 63 | 3 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 5.66e-09 | 3 | 63 | 3 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 5.66e-09 | 3 | 63 | 3 | 11944992 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 5.66e-09 | 3 | 63 | 3 | 17035546 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 5.66e-09 | 3 | 63 | 3 | 25423136 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.44e-08 | 351 | 63 | 9 | 38297188 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 2.26e-08 | 4 | 63 | 3 | 14983056 | |
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 32706374 | ||
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 8786425 | ||
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 2.26e-08 | 4 | 63 | 3 | 32134527 | |
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 2.26e-08 | 4 | 63 | 3 | 33888718 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DHX15 SEMA3A GTF2A1 TSC22D1 NEO1 SLC30A5 ATN1 SLC39A9 SLC39A6 CHD8 RERE SLC39A14 SLC39A10 CREB5 SLC39A7 | 3.48e-08 | 1451 | 63 | 15 | 30550785 |
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 28472659 | ||
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 36709330 | ||
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.65e-08 | 5 | 63 | 3 | 18923512 | |
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 9223334 | ||
| Pubmed | 6.41e-08 | 418 | 63 | 9 | 34709266 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 7.11e-08 | 197 | 63 | 7 | 20811636 | |
| Pubmed | Expression of a large family of POU-domain regulatory genes in mammalian brain development. | 1.13e-07 | 6 | 63 | 3 | 2739723 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.13e-07 | 6 | 63 | 3 | 12827191 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.13e-07 | 6 | 63 | 3 | 8576240 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 30683685 | ||
| Pubmed | 1.15e-07 | 126 | 63 | 6 | 16284245 | ||
| Pubmed | 1.42e-07 | 26 | 63 | 4 | 22992956 | ||
| Pubmed | 1.94e-07 | 28 | 63 | 4 | 38324473 | ||
| Pubmed | 2.24e-07 | 29 | 63 | 4 | 30846445 | ||
| Pubmed | 2.59e-07 | 30 | 63 | 4 | 24302887 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 12659941 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.15e-07 | 8 | 63 | 3 | 30871858 | |
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 37591863 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 23293286 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 37590135 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 34919427 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 8276396 | ||
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 9707552 | ||
| Pubmed | 5.71e-07 | 268 | 63 | 7 | 33640491 | ||
| Pubmed | 6.74e-07 | 10 | 63 | 3 | 29990475 | ||
| Pubmed | Spatiotemporal expression of Zic genes during vertebrate inner ear development. | 6.74e-07 | 10 | 63 | 3 | 23606270 | |
| Pubmed | PRC1 sustains the integrity of neural fate in the absence of PRC2 function. | 6.89e-07 | 38 | 63 | 4 | 34994686 | |
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 6.89e-07 | 38 | 63 | 4 | 25519132 | |
| Pubmed | LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain. | 8.51e-07 | 40 | 63 | 4 | 26795843 | |
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 28814342 | ||
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 23637331 | ||
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 32973045 | ||
| Pubmed | SORBS2 NRXN1 IQSEC2 CHD8 TNKS CHD7 ZNF318 PRRT1 TENM2 SHISA7 FOXG1 | 1.15e-06 | 963 | 63 | 11 | 28671696 | |
| Pubmed | Ascl1 expression defines a subpopulation of lineage-restricted progenitors in the mammalian retina. | 1.23e-06 | 12 | 63 | 3 | 21771810 | |
| Pubmed | 1.64e-06 | 47 | 63 | 4 | 28219675 | ||
| Pubmed | 2.00e-06 | 205 | 63 | 6 | 20436479 | ||
| Pubmed | Cytoneme signaling provides essential contributions to mammalian tissue patterning. | 2.03e-06 | 14 | 63 | 3 | 38171360 | |
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 2.03e-06 | 14 | 63 | 3 | 25450229 | |
| Pubmed | The role of Sema3-Npn-1 signaling during diaphragm innervation and muscle development. | 2.03e-06 | 14 | 63 | 3 | 27466379 | |
| Pubmed | Loss of Axin2 Causes Ocular Defects During Mouse Eye Development. | 2.54e-06 | 15 | 63 | 3 | 27701636 | |
| Pubmed | Integral bHLH factor regulation of cell cycle exit and RGC differentiation. | 2.54e-06 | 15 | 63 | 3 | 29770538 | |
| Pubmed | 2.68e-06 | 53 | 63 | 4 | 27210758 | ||
| Pubmed | Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalon. | 3.12e-06 | 16 | 63 | 3 | 15708565 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 27391320 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24587242 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8537352 | ||
| Pubmed | Brn3 transcription factors control terminal osteoclastogenesis. | 3.23e-06 | 2 | 63 | 2 | 17668438 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11891044 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21248196 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 37543682 | ||
| Pubmed | Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. | 3.23e-06 | 2 | 63 | 2 | 15642354 | |
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 3.23e-06 | 2 | 63 | 2 | 9430716 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10814707 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30709877 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8995448 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 3.23e-06 | 2 | 63 | 2 | 20453063 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8234287 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25969539 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19658047 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24211491 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24975120 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 27274087 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 35798741 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29432577 | ||
| Interaction | RNF4 interactions | DHX15 CCNT1 CCNT2 GTF2A1 TSC22D1 ZNF609 OTX1 ATN1 IQSEC2 ARID5B AUTS2 SLC39A6 FGFRL1 GSX2 CHD8 TNKS RERE SLC39A14 SLC39A10 FOXA2 CREB5 SLC39A7 FOXG1 ZIC3 | 1.77e-12 | 1412 | 63 | 24 | int:RNF4 |
| Interaction | KDM5B interactions | 2.64e-08 | 100 | 63 | 7 | int:KDM5B | |
| Interaction | KRTAP4-12 interactions | 3.72e-08 | 161 | 63 | 8 | int:KRTAP4-12 | |
| Interaction | RGS19 interactions | 1.02e-07 | 37 | 63 | 5 | int:RGS19 | |
| Interaction | KRTAP3-2 interactions | 1.70e-07 | 79 | 63 | 6 | int:KRTAP3-2 | |
| Interaction | GSC interactions | 3.03e-07 | 87 | 63 | 6 | int:GSC | |
| Interaction | LCE2C interactions | 3.25e-07 | 88 | 63 | 6 | int:LCE2C | |
| Interaction | KRTAP19-2 interactions | 3.52e-07 | 47 | 63 | 5 | int:KRTAP19-2 | |
| Interaction | KRTAP9-2 interactions | 4.10e-07 | 149 | 63 | 7 | int:KRTAP9-2 | |
| Interaction | LCE1F interactions | 4.23e-07 | 92 | 63 | 6 | int:LCE1F | |
| Interaction | KRTAP12-4 interactions | 6.49e-07 | 53 | 63 | 5 | int:KRTAP12-4 | |
| Interaction | KRTAP9-8 interactions | 6.93e-07 | 100 | 63 | 6 | int:KRTAP9-8 | |
| Interaction | KRTAP5-4 interactions | 1.55e-06 | 63 | 63 | 5 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 1.68e-06 | 64 | 63 | 5 | int:KRTAP10-11 | |
| Interaction | RGS20 interactions | 1.83e-06 | 118 | 63 | 6 | int:RGS20 | |
| Interaction | KRTAP5-11 interactions | 1.96e-06 | 66 | 63 | 5 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 1.96e-06 | 66 | 63 | 5 | int:KRTAP5-3 | |
| Interaction | KRTAP9-4 interactions | 3.31e-06 | 33 | 63 | 4 | int:KRTAP9-4 | |
| Interaction | KRTAP4-5 interactions | 3.96e-06 | 76 | 63 | 5 | int:KRTAP4-5 | |
| Interaction | LCE1C interactions | 4.22e-06 | 77 | 63 | 5 | int:LCE1C | |
| Interaction | KRTAP9-3 interactions | 4.95e-06 | 140 | 63 | 6 | int:KRTAP9-3 | |
| Interaction | KRTAP1-1 interactions | 5.37e-06 | 219 | 63 | 7 | int:KRTAP1-1 | |
| Interaction | KRTAP4-4 interactions | 5.42e-06 | 81 | 63 | 5 | int:KRTAP4-4 | |
| Interaction | AUTS2 interactions | 7.28e-06 | 40 | 63 | 4 | int:AUTS2 | |
| Interaction | LCE5A interactions | 9.10e-06 | 90 | 63 | 5 | int:LCE5A | |
| Interaction | KRTAP4-11 interactions | 1.01e-05 | 92 | 63 | 5 | int:KRTAP4-11 | |
| Interaction | FBLN5 interactions | 1.03e-05 | 159 | 63 | 6 | int:FBLN5 | |
| Interaction | TERF2 interactions | 1.04e-05 | 340 | 63 | 8 | int:TERF2 | |
| Interaction | CHRD interactions | 1.13e-05 | 94 | 63 | 5 | int:CHRD | |
| Interaction | KRTAP5-6 interactions | 1.13e-05 | 94 | 63 | 5 | int:KRTAP5-6 | |
| Interaction | CFD interactions | DHX15 SEMA3A GTF2A1 TSC22D1 NEO1 SLC30A5 ATN1 SLC39A9 SLC39A6 CHD8 RERE SLC39A14 SLC39A10 CREB5 SLC39A7 | 1.42e-05 | 1360 | 63 | 15 | int:CFD |
| Interaction | KRTAP1-5 interactions | 1.52e-05 | 48 | 63 | 4 | int:KRTAP1-5 | |
| Interaction | RGS17 interactions | 1.52e-05 | 48 | 63 | 4 | int:RGS17 | |
| Interaction | EGR2 interactions | 1.56e-05 | 171 | 63 | 6 | int:EGR2 | |
| Interaction | PLSCR1 interactions | 1.61e-05 | 172 | 63 | 6 | int:PLSCR1 | |
| Interaction | TAF1 interactions | 1.64e-05 | 260 | 63 | 7 | int:TAF1 | |
| Interaction | KRTAP6-1 interactions | 1.76e-05 | 103 | 63 | 5 | int:KRTAP6-1 | |
| Interaction | LGALS13 interactions | 1.92e-05 | 17 | 63 | 3 | int:LGALS13 | |
| Interaction | TLE3 interactions | 2.16e-05 | 376 | 63 | 8 | int:TLE3 | |
| Interaction | TSPAN4 interactions | 2.26e-05 | 53 | 63 | 4 | int:TSPAN4 | |
| Interaction | PHF20 interactions | 2.26e-05 | 53 | 63 | 4 | int:PHF20 | |
| Interaction | KRTAP6-2 interactions | 2.58e-05 | 187 | 63 | 6 | int:KRTAP6-2 | |
| Interaction | GRN interactions | 2.70e-05 | 281 | 63 | 7 | int:GRN | |
| Interaction | KRTAP10-8 interactions | 3.41e-05 | 401 | 63 | 8 | int:KRTAP10-8 | |
| Interaction | FNDC5 interactions | DHX15 SEMA3A GTF2A1 TSC22D1 NEO1 SLC30A5 ATN1 SLC39A9 SLC39A6 CHD8 RERE SLC39A14 SLC39A10 CREB5 SLC39A7 | 3.55e-05 | 1470 | 63 | 15 | int:FNDC5 |
| Interaction | KRTAP5-9 interactions | 4.09e-05 | 203 | 63 | 6 | int:KRTAP5-9 | |
| Interaction | VWC2 interactions | 4.22e-05 | 62 | 63 | 4 | int:VWC2 | |
| Interaction | NLGN1 interactions | 4.30e-05 | 22 | 63 | 3 | int:NLGN1 | |
| Interaction | SP7 interactions | 4.45e-05 | 304 | 63 | 7 | int:SP7 | |
| Interaction | KRTAP12-2 interactions | 5.00e-05 | 128 | 63 | 5 | int:KRTAP12-2 | |
| Interaction | MDFI interactions | 5.58e-05 | 430 | 63 | 8 | int:MDFI | |
| Interaction | KRTAP4-2 interactions | 5.79e-05 | 132 | 63 | 5 | int:KRTAP4-2 | |
| Interaction | EFEMP2 interactions | 6.67e-05 | 136 | 63 | 5 | int:EFEMP2 | |
| Interaction | CHIC2 interactions | 8.03e-05 | 73 | 63 | 4 | int:CHIC2 | |
| Interaction | KRTAP10-10 interactions | 8.07e-05 | 27 | 63 | 3 | int:KRTAP10-10 | |
| Interaction | KRTAP12-3 interactions | 9.34e-05 | 146 | 63 | 5 | int:KRTAP12-3 | |
| Interaction | TRIM42 interactions | 1.03e-04 | 149 | 63 | 5 | int:TRIM42 | |
| Interaction | KRTAP10-9 interactions | 1.06e-04 | 241 | 63 | 6 | int:KRTAP10-9 | |
| Interaction | KRTAP19-6 interactions | 1.09e-04 | 79 | 63 | 4 | int:KRTAP19-6 | |
| Interaction | EYA4 interactions | 1.11e-04 | 243 | 63 | 6 | int:EYA4 | |
| Interaction | LCE4A interactions | 1.15e-04 | 80 | 63 | 4 | int:LCE4A | |
| Interaction | KRTAP10-1 interactions | 1.16e-04 | 153 | 63 | 5 | int:KRTAP10-1 | |
| Interaction | KRTAP4-1 interactions | 1.23e-04 | 31 | 63 | 3 | int:KRTAP4-1 | |
| Interaction | POU3F4 interactions | 1.43e-04 | 6 | 63 | 2 | int:POU3F4 | |
| Interaction | KRTAP10-5 interactions | 1.44e-04 | 160 | 63 | 5 | int:KRTAP10-5 | |
| Interaction | KDM1A interactions | DHX15 ZNF609 TET1 ARID5B DVL3 CHD8 CHD7 ZNF318 RERE SLC39A7 FOXG1 | 1.44e-04 | 941 | 63 | 11 | int:KDM1A |
| Interaction | KRTAP6-3 interactions | 1.48e-04 | 161 | 63 | 5 | int:KRTAP6-3 | |
| Interaction | CYP21A2 interactions | 1.49e-04 | 33 | 63 | 3 | int:CYP21A2 | |
| Interaction | SPRY3 interactions | 1.77e-04 | 35 | 63 | 3 | int:SPRY3 | |
| Interaction | CYSRT1 interactions | 1.84e-04 | 511 | 63 | 8 | int:CYSRT1 | |
| Interaction | SETD1A interactions | 1.91e-04 | 170 | 63 | 5 | int:SETD1A | |
| Interaction | RERE interactions | 2.06e-04 | 93 | 63 | 4 | int:RERE | |
| Interaction | ZNF608 interactions | 2.06e-04 | 93 | 63 | 4 | int:ZNF608 | |
| Interaction | TLX1 interactions | 2.18e-04 | 175 | 63 | 5 | int:TLX1 | |
| Interaction | KRTAP19-5 interactions | 2.61e-04 | 99 | 63 | 4 | int:KRTAP19-5 | |
| Interaction | KRTAP1-3 interactions | 2.75e-04 | 184 | 63 | 5 | int:KRTAP1-3 | |
| Interaction | ABTB2 interactions | 2.82e-04 | 101 | 63 | 4 | int:ABTB2 | |
| Interaction | RBM15B interactions | 2.82e-04 | 101 | 63 | 4 | int:RBM15B | |
| Interaction | ATN1 interactions | 2.96e-04 | 187 | 63 | 5 | int:ATN1 | |
| Interaction | SPRY1 interactions | 4.04e-04 | 111 | 63 | 4 | int:SPRY1 | |
| Interaction | BACH1 interactions | 4.04e-04 | 111 | 63 | 4 | int:BACH1 | |
| Interaction | PCSK5 interactions | 4.18e-04 | 112 | 63 | 4 | int:PCSK5 | |
| Interaction | P2RY2 interactions | 4.18e-04 | 112 | 63 | 4 | int:P2RY2 | |
| Interaction | KRTAP17-1 interactions | 4.55e-04 | 48 | 63 | 3 | int:KRTAP17-1 | |
| Interaction | TBXT interactions | 4.78e-04 | 116 | 63 | 4 | int:TBXT | |
| Interaction | DLG4 interactions | 4.91e-04 | 449 | 63 | 7 | int:DLG4 | |
| Interaction | THSD4 interactions | 5.14e-04 | 50 | 63 | 3 | int:THSD4 | |
| Interaction | ARL14 interactions | 5.26e-04 | 119 | 63 | 4 | int:ARL14 | |
| Interaction | ADAMTSL4 interactions | 5.85e-04 | 217 | 63 | 5 | int:ADAMTSL4 | |
| Interaction | ALPP interactions | 5.96e-04 | 123 | 63 | 4 | int:ALPP | |
| Interaction | KRTAP10-4 interactions | 6.22e-04 | 12 | 63 | 2 | int:KRTAP10-4 | |
| Interaction | PHF21A interactions | 6.99e-04 | 343 | 63 | 6 | int:PHF21A | |
| Interaction | PAX9 interactions | 7.34e-04 | 130 | 63 | 4 | int:PAX9 | |
| Interaction | ZNF699 interactions | 8.54e-04 | 14 | 63 | 2 | int:ZNF699 | |
| Interaction | ARL4C interactions | 8.68e-04 | 136 | 63 | 4 | int:ARL4C | |
| Interaction | ANKRD36B interactions | 8.77e-04 | 60 | 63 | 3 | int:ANKRD36B | |
| Interaction | AR interactions | 9.48e-04 | 992 | 63 | 10 | int:AR | |
| Interaction | KRTAP22-1 interactions | 9.84e-04 | 15 | 63 | 2 | int:KRTAP22-1 | |
| Interaction | KRTAP12-1 interactions | 1.01e-03 | 63 | 63 | 3 | int:KRTAP12-1 | |
| Interaction | PLAGL2 interactions | 1.01e-03 | 63 | 63 | 3 | int:PLAGL2 | |
| Cytoband | 3q27 | 5.62e-04 | 25 | 64 | 2 | 3q27 | |
| Cytoband | 8p21.3 | 1.30e-03 | 38 | 64 | 2 | 8p21.3 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 3.73e-07 | 23 | 48 | 4 | 523 | |
| GeneFamily | Solute carriers | SLC30A5 SLC11A1 SLC39A9 SLC39A6 SLC39A14 SLC39A10 SLC4A3 SLC39A7 | 8.49e-06 | 395 | 48 | 8 | 752 |
| GeneFamily | Cyclins|P-TEFb complex | 4.13e-05 | 4 | 48 | 2 | 1281 | |
| GeneFamily | Cyclins | 2.50e-03 | 28 | 48 | 2 | 473 | |
| GeneFamily | Forkhead boxes | 5.81e-03 | 43 | 48 | 2 | 508 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.73e-03 | 53 | 48 | 2 | 532 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | OLIG3 OTX1 NRXN1 ARID5B SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 PRRT1 FOXA2 OLIG2 FOXG1 | 2.52e-07 | 1115 | 62 | 14 | M10371 |
| Coexpression | BENPORATH_EED_TARGETS | OLIG3 OTX1 EPB41L4B AUTS2 SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 FOXA2 OLIG2 FOXG1 | 9.37e-07 | 1059 | 62 | 13 | M7617 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | OLIG3 NRXN2 INSL3 GSX2 POU4F1 POU4F2 PRRT1 FOXA2 OLIG2 FOXG1 | 1.18e-06 | 591 | 62 | 10 | M2019 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | OLIG3 NRXN2 INSL3 GSX2 POU4F1 POU4F2 PRRT1 FOXA2 OLIG2 FOXG1 | 1.37e-06 | 601 | 62 | 10 | MM866 |
| Coexpression | BENPORATH_PRC2_TARGETS | OTX1 SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 FOXA2 OLIG2 FOXG1 | 2.76e-06 | 650 | 62 | 10 | M8448 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN | 7.89e-06 | 200 | 62 | 6 | M7415 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 1.41e-05 | 335 | 62 | 7 | M39065 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SEMA3A NRXN3 NRXN1 NRXN2 TMEM121B AUTS2 SHOX2 TNKS ZNF318 TENM2 SLC4A3 | 5.06e-05 | 1106 | 62 | 11 | M39071 |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP | 8.36e-05 | 188 | 62 | 5 | M3332 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP | 1.07e-04 | 198 | 62 | 5 | M5083 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.07e-04 | 198 | 62 | 5 | M8624 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.12e-04 | 465 | 62 | 7 | M39066 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | OTX1 SHOX2 GSX2 POU3F1 POU3F4 POU4F1 POU4F2 FOXA2 OLIG2 FOXG1 | 1.47e-04 | 1035 | 62 | 10 | M9898 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | 1.51e-04 | 488 | 62 | 7 | M39104 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 1.96e-04 | 681 | 62 | 8 | M5314 | |
| Coexpression | HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN | 2.02e-04 | 48 | 62 | 3 | M4339 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | ZNF609 SORBS2 NRXN3 NRXN2 FBRSL1 POU3F1 TRIM71 POU3F4 CHD7 OLIG2 TENM2 FOXG1 ZIC3 | 1.66e-09 | 482 | 64 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.98e-09 | 121 | 64 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | OTX1 SORBS2 NRXN3 NRXN2 POU3F1 TRIM71 POU3F4 CHD7 OLIG2 CREB5 FOXG1 ZIC3 | 2.36e-08 | 493 | 64 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.51e-08 | 248 | 64 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | OTX1 SORBS2 NRXN2 TET1 POU3F1 TRIM71 POU3F4 CHD7 SLC39A14 OLIG2 ZIC3 | 2.41e-07 | 495 | 64 | 11 | Facebase_RNAseq_e8.5_Floor Plate_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 2.69e-07 | 145 | 64 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_100 | 5.31e-07 | 99 | 64 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | ZNF609 SORBS2 NRXN3 NRXN2 DVL3 FBRSL1 POU3F1 TRIM71 POU3F4 CHD7 OLIG2 TENM2 FOXG1 ZIC3 | 9.91e-07 | 979 | 64 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.00e-06 | 350 | 64 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 1.04e-06 | 111 | 64 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.04e-06 | 196 | 64 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | OTX1 SORBS2 NRXN2 POU3F1 TRIM71 POU3F4 CHD7 OLIG2 FOXG1 ZIC3 | 2.24e-06 | 498 | 64 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.43e-06 | 212 | 64 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 4.03e-06 | 79 | 64 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | OTX1 SORBS2 NRXN3 NRXN1 NRXN2 ARID5B POU3F1 TRIM71 CHD7 TENM2 CREB5 FOXG1 ZIC3 | 5.60e-06 | 976 | 64 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | OTX1 SORBS2 NRXN3 NRXN2 POU3F1 TRIM71 POU3F4 CHD8 CHD7 OLIG2 CREB5 FOXG1 ZIC3 | 6.05e-06 | 983 | 64 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | CCNT1 OTX1 SORBS2 NRXN2 TET1 POU3F1 TRIM71 POU3F4 CHD7 SLC39A14 SLC39A10 OLIG2 ZIC3 | 6.82e-06 | 994 | 64 | 13 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 7.65e-06 | 90 | 64 | 5 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 1.28e-05 | 100 | 64 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_100 | 1.28e-05 | 100 | 64 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 1.51e-05 | 489 | 64 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.55e-05 | 177 | 64 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 1.69e-05 | 496 | 64 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 1.69e-05 | 496 | 64 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.05e-05 | 279 | 64 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.86e-05 | 118 | 64 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ZNF609 SORBS2 NRXN3 NRXN2 EPB41L4B POU3F1 TRIM71 CHD8 CHD7 OLIG2 FOXG1 ZIC3 | 3.31e-05 | 986 | 64 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.35e-05 | 122 | 64 | 5 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | OTX1 SORBS2 CATSPER1 NRXN2 POU3F1 TRIM71 POU3F4 CHD7 OLIG2 TENM2 FOXG1 ZIC3 | 3.41e-05 | 989 | 64 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.62e-05 | 419 | 64 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | SEMA3A GTF2A1 TSC22D1 NEO1 SLC30A5 AUTS2 TNKS CHD7 CACHD1 SLC39A10 SLC4A3 | 3.68e-05 | 837 | 64 | 11 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.05e-05 | 210 | 64 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.80e-05 | 224 | 64 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 6.27e-05 | 71 | 64 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZNF609 SORBS2 NRXN3 NRXN1 NRXN2 CHD8 CHD7 OLIG2 CREB5 FOXG1 ZIC3 | 6.60e-05 | 893 | 64 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.07e-05 | 339 | 64 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 7.89e-05 | 345 | 64 | 7 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 1.16e-04 | 495 | 64 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.49e-04 | 266 | 64 | 6 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | OTX1 SORBS2 NRXN3 NRXN1 ARID5B TRIM71 CHD7 OLIG2 TENM2 CREB5 FOXG1 | 1.56e-04 | 984 | 64 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 2.19e-04 | 98 | 64 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_100 | 2.19e-04 | 98 | 64 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 2.28e-04 | 99 | 64 | 4 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 2.37e-04 | 100 | 64 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | cerebral cortex | OTX1 NRXN3 NRXN1 NRXN2 POU3F4 SLC39A10 PRRT1 OLIG2 TENM2 SLC4A3 SHISA7 FOXG1 ZIC3 | 2.84e-04 | 1428 | 64 | 13 | cerebral cortex |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.18e-04 | 108 | 64 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.30e-04 | 732 | 64 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.84e-04 | 205 | 64 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.86e-04 | 447 | 64 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 4.73e-04 | 769 | 64 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.37e-04 | 124 | 64 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | SEMA3A GTF2A1 TSC22D1 NEO1 SLC30A5 CHD7 CACHD1 SLC39A10 SLC4A3 | 5.80e-04 | 791 | 64 | 9 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.88e-04 | 127 | 64 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | OTX1 SORBS2 NRXN3 NRXN1 ARID5B TRIM71 CHD7 TENM2 CREB5 FOXG1 | 6.22e-04 | 973 | 64 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 6.42e-04 | 487 | 64 | 7 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | SEMA3A GTF2A1 NEO1 SORBS2 SLC30A5 CHD7 SLC39A10 SLC4A3 AXIN2 | 6.46e-04 | 803 | 64 | 9 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 6.89e-04 | 986 | 64 | 10 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | ATN1 NRXN1 IQSEC2 TET1 ARID5B DVL3 CACHD1 SLC39A14 SLC4A3 CREB5 AXIN2 | 8.89e-04 | 1208 | 64 | 11 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.48e-04 | 377 | 64 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.58e-04 | 251 | 64 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 1.01e-03 | 147 | 64 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_100 | 1.04e-03 | 16 | 64 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#4 | 1.09e-03 | 67 | 64 | 3 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.10e-03 | 259 | 64 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_100 | 1.14e-03 | 68 | 64 | 3 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_100 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#1_top-relative-expression-ranked_200 | 1.18e-03 | 17 | 64 | 2 | gudmap_kidney_e10.5_UretericTip_HoxB7_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.20e-03 | 395 | 64 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 1.35e-03 | 404 | 64 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 1.36e-03 | 159 | 64 | 4 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.39e-03 | 160 | 64 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.48e-03 | 727 | 64 | 8 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_250 | 1.55e-03 | 165 | 64 | 4 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_250 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 1.66e-03 | 168 | 64 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.69e-03 | 78 | 64 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.76e-03 | 747 | 64 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | e10.5_NeuroEpith_LateralEmin_top-relative-expression-ranked_250 | 1.85e-03 | 173 | 64 | 4 | Facebase_ST1_e10.5_NeuroEpith_LateralEmin_250 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.95e-03 | 295 | 64 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-07 | 200 | 64 | 6 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 3.33e-06 | 159 | 64 | 5 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 4.62e-06 | 170 | 64 | 5 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-06 | 177 | 64 | 5 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 181 | 64 | 5 | 064057ab36c6d92c36572b73142b42d201709d7b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-06 | 182 | 64 | 5 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 186 | 64 | 5 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 187 | 64 | 5 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 187 | 64 | 5 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 190 | 64 | 5 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.94e-06 | 190 | 64 | 5 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 190 | 64 | 5 | 4971857eac9af17d66d673ed2ab7072639f60a10 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.56e-06 | 193 | 64 | 5 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 193 | 64 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 8.56e-06 | 193 | 64 | 5 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 8.56e-06 | 193 | 64 | 5 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 193 | 64 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 193 | 64 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.23e-06 | 196 | 64 | 5 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-06 | 198 | 64 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-06 | 198 | 64 | 5 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 9.69e-06 | 198 | 64 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.93e-06 | 199 | 64 | 5 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 200 | 64 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 200 | 64 | 5 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-05 | 200 | 64 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 200 | 64 | 5 | 553e9612874480f4d2a45671462e266cd0a09321 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.81e-05 | 146 | 64 | 4 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.09e-05 | 159 | 64 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-05 | 166 | 64 | 4 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-05 | 166 | 64 | 4 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.78e-05 | 167 | 64 | 4 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 168 | 64 | 4 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 169 | 64 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 172 | 64 | 4 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 173 | 64 | 4 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 174 | 64 | 4 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-04 | 176 | 64 | 4 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 177 | 64 | 4 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 177 | 64 | 4 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-04 | 179 | 64 | 4 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 181 | 64 | 4 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 182 | 64 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 182 | 64 | 4 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-04 | 183 | 64 | 4 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 183 | 64 | 4 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 184 | 64 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 184 | 64 | 4 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 184 | 64 | 4 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 184 | 64 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 185 | 64 | 4 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 64 | 4 | adba5647a2feaba8e361dc1020d2f2dc4ce36b16 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 186 | 64 | 4 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 186 | 64 | 4 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 186 | 64 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.51e-04 | 187 | 64 | 4 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 188 | 64 | 4 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 189 | 64 | 4 | f44ddb6cdbb406b0528a9b0ba3811183ab6d1fc6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 190 | 64 | 4 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.61e-04 | 190 | 64 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.61e-04 | 190 | 64 | 4 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-04 | 190 | 64 | 4 | a28e14fff75c36b1a8634eaf3f305e3206fdc2ed | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 190 | 64 | 4 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 192 | 64 | 4 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 192 | 64 | 4 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.67e-04 | 192 | 64 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 192 | 64 | 4 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 193 | 64 | 4 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 193 | 64 | 4 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 193 | 64 | 4 | e477f5ddbb9d5878560998250ca0e1a5467953f4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.71e-04 | 193 | 64 | 4 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 64 | 4 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 194 | 64 | 4 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 194 | 64 | 4 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-04 | 196 | 64 | 4 | fe2dd3a93fe22da93e24a400e154a68757985fc8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 196 | 64 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.81e-04 | 196 | 64 | 4 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 196 | 64 | 4 | e874aa82a20bb59582c8cd7f8d30b2ed02903a85 | |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | 1.25e-06 | 195 | 64 | 7 | 4428_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.34e-06 | 197 | 64 | 7 | 4285_UP | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.43e-06 | 199 | 64 | 7 | 6634_UP | |
| Drug | Dicyclohexylcarbodiimide | 7.78e-06 | 2 | 64 | 2 | ctd:D004024 | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.71e-05 | 193 | 64 | 6 | 3250_UP | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 6084_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 1.76e-05 | 194 | 64 | 6 | 263_UP | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 4399_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; PC3; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 3826_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 5499_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 7474_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 3990_UP | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 4194_DN | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 2132_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 4982_UP | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 7544_DN | |
| Drug | AC1NDQQ3 | 4.66e-05 | 25 | 64 | 3 | CID004630067 | |
| Drug | AC1L1C6C | 6.59e-05 | 77 | 64 | 4 | CID000001759 | |
| Drug | ATN-2 | 1.16e-04 | 6 | 64 | 2 | CID003081684 | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.69e-04 | 184 | 64 | 5 | 2168_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.96e-04 | 190 | 64 | 5 | 4274_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 7147_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 5268_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2844_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6059_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4201_DN | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6131_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6695_UP | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4676_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4200_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2843_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4683_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4560_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 7495_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 6754_UP | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 2249_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 6722_UP | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 2457_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3801_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3777_DN | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 4142_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 5753_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HG-U133A | 2.32e-04 | 197 | 64 | 5 | 1933_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 3769_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 2328_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 4299_UP | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 2458_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 4185_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 5867_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 4977_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 3756_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 4005_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 5865_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6078_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 4115_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; PC3; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 6661_UP | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 4210_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 6489_UP | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 200 | 64 | 5 | 4797_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 200 | 64 | 5 | 7329_UP | |
| Disease | Autism Spectrum Disorders | 9.23e-07 | 85 | 61 | 5 | C1510586 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 4.20e-06 | 2 | 61 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.60e-05 | 152 | 61 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | social interaction measurement | 4.39e-05 | 94 | 61 | 4 | EFO_0009592 | |
| Disease | chronotype measurement | 7.87e-05 | 882 | 61 | 9 | EFO_0008328 | |
| Disease | cortical surface area measurement | NEO1 AUTS2 FGFRL1 TRIM71 TNKS CHD7 CACHD1 RERE PRRT1 TENM2 FOXG1 | 8.68e-05 | 1345 | 61 | 11 | EFO_0010736 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.77e-05 | 7 | 61 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Tinnitus | 1.55e-04 | 130 | 61 | 4 | HP_0000360 | |
| Disease | risk-taking behaviour | 1.71e-04 | 764 | 61 | 8 | EFO_0008579 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.35e-04 | 801 | 61 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | cup-to-disc ratio measurement | 2.61e-04 | 430 | 61 | 6 | EFO_0006939 | |
| Disease | testosterone measurement | SEMA3A NRXN1 IQSEC2 ARID5B AUTS2 FGFRL1 GSX2 CHD7 ZNF318 PRRT1 | 2.65e-04 | 1275 | 61 | 10 | EFO_0004908 |
| Disease | Intellectual Disability | 3.21e-04 | 447 | 61 | 6 | C3714756 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.00e-04 | 69 | 61 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | reaction time measurement | 4.08e-04 | 658 | 61 | 7 | EFO_0008393 | |
| Disease | lung cancer (is_implicated_in) | 4.91e-04 | 74 | 61 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.95e-04 | 16 | 61 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | smoking cessation | 5.64e-04 | 325 | 61 | 5 | EFO_0004319 | |
| Disease | nose morphology measurement | 5.96e-04 | 329 | 61 | 5 | EFO_0007843 | |
| Disease | Epilepsy, Cryptogenic | 6.63e-04 | 82 | 61 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 6.63e-04 | 82 | 61 | 3 | C0751111 | |
| Disease | Aura | 6.63e-04 | 82 | 61 | 3 | C0236018 | |
| Disease | facial asymmetry measurement | 7.03e-04 | 19 | 61 | 2 | EFO_0009751 | |
| Disease | vital capacity | 9.40e-04 | 1236 | 61 | 9 | EFO_0004312 | |
| Disease | cerebrospinal fluid biomarker measurement | 1.05e-03 | 96 | 61 | 3 | EFO_0006794 | |
| Disease | Kallmann Syndrome | 1.32e-03 | 26 | 61 | 2 | C0162809 | |
| Disease | caudate volume change measurement, age at assessment | 1.43e-03 | 27 | 61 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | Epilepsy | 1.51e-03 | 109 | 61 | 3 | C0014544 | |
| Disease | urate measurement, bone density | 1.74e-03 | 619 | 61 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | cortical thickness | 2.00e-03 | 1113 | 61 | 8 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTHAHTHAHTHGHTH | 116 | Q6ZRP5 | |
| THAHTHGHTHTRAHS | 121 | Q6ZRP5 | |
| HGHTHTRAHSTHAHT | 126 | Q6ZRP5 | |
| TRAHSTHAHTHAHSH | 131 | Q6ZRP5 | |
| THAHTHAHSHYHTRT | 136 | Q6ZRP5 | |
| RAEFHQHQHTHQHTH | 436 | Q9HCM7 | |
| QHQHTHQHTHQHTHQ | 441 | Q9HCM7 | |
| HQHTHQHTHQHQHTF | 446 | Q9HCM7 | |
| FEFHRHTSHHTHHPL | 71 | P48751 | |
| VDSSTMLHHHHHHPH | 2486 | Q9HCK8 | |
| SRHHTSSHKHSHSHS | 566 | O60583 | |
| FHDQALSSHVHQSHH | 66 | Q8NEC5 | |
| LSSHVHQSHHHSEAR | 71 | Q8NEC5 | |
| DHPHHTQHHYHQTHR | 281 | Q8NEC5 | |
| TAHPPVSTHHHHHQQ | 471 | P54259 | |
| NVTPHHHQHSHIHSH | 1046 | P54259 | |
| HIHSHLHLHQQDAIH | 1056 | P54259 | |
| HHPTLHHSHHLQAAV | 1251 | Q5VU97 | |
| PAAAANHHHHHHHAL | 326 | A6QL63 | |
| SPRSRSPDHHHHHHS | 461 | Q9Y2T1 | |
| SPDHHHHHHSQYHSL | 466 | Q9Y2T1 | |
| KTHPSNHHHHHNHHS | 511 | O60563 | |
| HNHHSHKHSHSQLPV | 521 | O60563 | |
| HSAHSTHSAHSTHST | 81 | O43143 | |
| THSAHSTHSTHSAHS | 86 | O43143 | |
| SHHSLASSLRSHHTH | 636 | Q92997 | |
| HSVQQFHHHPSTALH | 251 | Q9P2D1 | |
| QDQTPHHHMHSHPHQ | 266 | Q02930 | |
| HHQQNHPHHHSHSHL | 306 | Q02930 | |
| SHSHLHAHPAHHQTS | 316 | Q02930 | |
| TSTSTVPLAHHHHHH | 91 | Q01851 | |
| AHHIHHFHGSSKHHS | 56 | P58400 | |
| SHNNNSSDLHPHKHH | 341 | P04196 | |
| SSDLHPHKHHSHEQH | 346 | P04196 | |
| HHAHHAHPRASASAP | 151 | Q2Q1W2 | |
| SSSSASSTHHHHHHH | 1231 | Q5JU85 | |
| AQFCPRVNHAHHHHH | 116 | Q9BZM3 | |
| DNHHASHGHHNSHHP | 31 | P55316 | |
| TDIHTHTHTHSHTHS | 476 | Q8N441 | |
| HTHTHSHTHSHVEGK | 481 | Q8N441 | |
| QHQHQHQHTHQHTHQ | 526 | Q8WXX7 | |
| HQHTHQHTHQHTFTP | 531 | Q8WXX7 | |
| AALHHHHHHTLPGSV | 436 | Q03052 | |
| AHGATFLAHSSHHHF | 521 | P49279 | |
| HHRHHHHQESRLNSV | 26 | Q7RTU3 | |
| HHHHPHAHHPLSQSS | 276 | P32242 | |
| HAHHPLSQSSGHHHH | 281 | P32242 | |
| HRSPHVAHHSPHTNH | 96 | P49335 | |
| SLSTTHHVHHFHSKH | 56 | P58401 | |
| HHVHHFHSKHGTVPI | 61 | P58401 | |
| SHHRHHRSHCHRPKS | 61 | Q5TA78 | |
| SRHHPLDATTSSHHH | 426 | Q8NBF1 | |
| HRHTHTLTHTHTHRD | 111 | Q5T7N8 | |
| AAPSSHHHHHHHYHQ | 36 | Q99946 | |
| HHHHHHHYHQSGTAT | 41 | Q99946 | |
| KHFHSHNHQHSHNHL | 121 | Q9ULF5 | |
| HHLDHNNTHHFHNDS | 186 | Q9ULF5 | |
| HHHGHSHYASESLPS | 251 | Q15043 | |
| VVHEHEHSHDHTQLH | 91 | Q9NUM3 | |
| SGRHHHQHQHQHQHQ | 501 | Q9H329 | |
| HQHQHQHQHQHHSNY | 506 | Q9H329 | |
| QTSHHHRHHRAAATN | 96 | P51460 | |
| LMSSEQQHHHSHHHH | 381 | Q9Y261 | |
| AASGAHNHHLHHHHA | 256 | Q9BXQ6 | |
| SSSPGSHSQHEHHFH | 46 | Q9HDB5 | |
| SHSQHEHHFHGSKHH | 51 | Q9HDB5 | |
| ISHPSALAGTHHHHH | 161 | Q12837 | |
| HSLDNPHHHFHSSSL | 1256 | Q92859 | |
| PEDHQGHSDQHHHHH | 316 | Q9BYZ6 | |
| AVAHAHHHLHPHLAA | 256 | O60902 | |
| PSSLHAHHHHALHGS | 471 | A6NL88 | |
| HNHTLSHHHSSANSL | 256 | Q9NT68 | |
| AAAAHAAHHPAVHHP | 206 | Q13516 | |
| NVTPHHHQHSHIHSH | 1421 | Q9P2R6 | |
| HLQHGHHHPSHVAVA | 231 | Q15714 | |
| HCSDLHHDNHHGHSP | 566 | Q14563 | |
| AEHRHHLPSHRSHSH | 146 | P23327 | |
| SSESFYGSSHHHHHH | 631 | O94875 | |
| HDHHSHHNHAASGKN | 126 | Q13433 | |
| HLLPHSHASHHHSHS | 376 | Q13433 | |
| SHASHHHSHSHEEPA | 381 | Q13433 | |
| PHSSHSIINHHASIH | 836 | Q8NFU7 | |
| NHHHHHNVSASTTPK | 161 | P55201 | |
| HLHSLYRHTEHHLHN | 836 | Q14865 | |
| GHSHHSHHGHPSHQS | 201 | Q5T681 | |
| SHHGHPSHQSHSLPN | 206 | Q5T681 | |
| HHHHHHHQQAQPQQT | 81 | P52655 | |
| HHHHHHHTSQVPSYG | 91 | O60481 | |
| SHRHSHEDFHHGHSH | 46 | Q92504 | |
| HSHHTLEQPGHGHSH | 196 | Q92504 | |
| MAASRRSQHHHHHHQ | 1 | O95271 | |
| RLMSTHHHHHHLGYS | 1361 | O15014 | |
| HHHHHHLGYSLLPAQ | 1366 | O15014 | |
| HSSDHSHSHHMHGHS | 556 | Q8TAD4 | |
| AHHSNTHSPEVSHPH | 681 | Q5VUA4 |